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Previous studies have shown that amylase levels are reduced
significantly in the pancreas and parotid gland of diabetic rats
and that insulin reverses this effect and increases the secretary
protein levels. In the pancreas, these changes in amylase pro-
tein levels are accompanied by parallel changes in amylase
mRNA levels. In the present study, the effects of diabetes and
subsequent insulin treatments on contents (per cell) of amylase
protein and its mRNA in parotid glands were compared in rats
rendered diabetic with an injection of a beta-cell toxin, strep-
tozotocin (STZ). Both amylase protein and its mRNA contents
were reduced significantly in diabetic rats, compared with con-
trol rats, and this reduction was reversed following insulin
injections of diabetic rats. In insulin-injected diabetic rats,
amylase protein contents increased before a detectable increase
in amylase mRNA levels was seen. The mRNA contents of a
non-secretory protein, actin, did not change during diabeto-
genesis or subsequent insulin treatments. The reductions in
parotid contents of amylase and its mRNA in diabetic rats and
the reversal of these changes by insulin are similar to those
changes that occur in the pancreas under the same conditions.
However, the magnitude of these changes in parotid glands
was much smaller than in the pancreas, and the effect of insulin
on amylase mRNA synthesis was not as immediate as in the
latter gland.
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Introduction.
Alpha-amylase is synthesized and secreted primarily by the
parotid salivary gland and pancreas. Parotid and pancreatic
amylases are encoded by two distinct genes: Amy-1 and Amy-
2, respectively (Hagenbuchle et al., 1980; Wiebauer et al.,
1985). Although the coding regions of the two genes are 90%
homologous (Hagenbuchle et al., 1980), these genes are as-
sociated with different promoters (Hagenbuchle et al., 1981;
Young et al., 1981; Osborn et al., 1987). In mice (Young et
al., 1981; Schibler et al., 1983) and rats (Sierra et al., 1986),
Amy-i is transcribed from a strong parotid-specific promoter
and a weaker one active in the liver, while Amy-2 is associated
with a single promoter. Thus, the expression of Amy-1 and
Amy-2 genes might be regulated independently.
In the pancreas, levels of amylase and its synthesis are af-
fected by diabetes. In experimental animals rendered diabetic
with either alloxan or streptozotocin (STZ), pancreatic amylase
levels fall progressively (Christophe et al., 1971; Ben Abdeljlil
et al., 1965; Snook, 1968; Soling and Unger, 1972; Korc et
al., 1981a, b). The effects of diabetes are specific for the
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individual enzymes, as is the case with dietary regulations of
pancreatic enzyme contents and synthesis (Schick et al., 1984a,
b). In the pancreas of diabetic rats, amylase activity is mark-
edly decreased, while activities of trypsinogen and chymo-
trypsinogen are increased (Ben Abdeljlil et al., 1965; Korc et
al., 1981b).
The in vivo administration of insulin to diabetic animals
reverses this decline in amylase content of the pancreas (Soling
and Unger, 1972; Korc et al., 1981a). The rate of amylase
synthesis increases, and this increase is also specific for amy-
lase and not for total pancreatic proteins (Soling and Unger,
1972; Korc et al., 1981b). The amylase mRNA level increases
with the increase in amylase protein synthesis, while chymo-
trypsinogen protein and its mRNA slightly decrease (Korc et
al., 1981b). These studies indicate a selective effect of insulin
on pancreatic amylase gene expression.
The effects of diabetes and insulin on amylase and its mRNA
in parotid glands are unclear. In rats rendered diabetic with an
injection of alloxan (Anderson and Johnson, 1981; Anderson,
1983), parotid levels of amylase were significantly less than
in control rats of comparable ages, and this effect was reversed
upon treatment with insulin (Anderson, 1983). On the other
hand, Palla et al. (1967) reported that the amylase levels in
parotid glands did not change in alloxan-induced diabetic rats.
Furthermore, it has been reported that diabetes or subsequent
insulin treatments have no significant effect on amylase protein
or mRNA levels in parotid glands of the rat (Korc et al.,
1981b).
We have examined the changes in levels of amylase protein
and its mRNA in parotid glands of rats that were rendered
diabetic with STZ and subsequently treated with insulin. The
changes in amylase mRNA levels were compared with the
levels of mRNA of a non-secretory protein, actin, for deter-
mination of whether diabetes and insulin specifically affected
this secretary protein messenger in parotid glands.
Materials and methods.
Rats. -Male Sprague-Dawley rats, obtained from Harlan
Sprague-Dawley, Inc. (Indianapolis, IN), were used in this
study. These rats were free of viruses and showed negative
immunological titers for sialodacryoadenitis (SDA) viruses,
which are known to affect the structure and function of salivary
glands (Jonas et al., 1969). Rats weighing 200-250 g were
given a single intraperitoneal injection of STZ (6.5 mg/100 g
body weight) in 10 mmol/L citrate buffer, pH 4.3 (Korc et al.,
1981b) for induction of diabetes. The concentration of STZ
was adjusted so that each rat received about 0.5 mL. Unin-
jected rats of comparable ages served as controls. A group of
diabetic rats was given daily injections of 4 units/100 g body
weight of Lente insulin (Eli Lilly and Co., Indianapolis, IN)
12 days after the STZ injection. Thus, the following groups
of rats were studied: D6 and D12 diabetic rats (six or 12 days,
respectively, following the injection of STZ) and D12-I1 and
D12-17 (animals receiving insulin injections for one or seven
days after being diabetic for 12 days). Parotid glands were
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removed at about the same time of the day (9:00 AM) for all
experiments so that the variability in secretary protein contents
would be reduced. However, the rats were not fasted, since
some diabetic rats did not survive overnight starving.
Serum glucose detenninations. -The serum level of glucose
was measured with a commercially available assay kit (Sigma,
St. Louis, MO). Blood was collected from rats by the tips of
their tails being cut off.
Amylase and protein assays. -Parotid amylase was ex-
tracted by homogenization of the gland in ice-cold distilled
water, and the enzyme level was determined by the method of
Bernfeld (1955), with starch used as the substrate. Protein
content was determined according to Lowry et al. (1951). Am-
ylase and protein contents were compared on a per-microgram
DNA basis as previously described (Kim, 1981; Kim et al.,
1980, 1981). The DNA content was determined by the di-
phenylamine method of Burton (1956) after extraction of DNA
with 0.5 mol/L perchloric acid from an aliquot of the glandular
homogenate. The homogenization of the gland in ice-cold dis-
tilled water or 0.5 mol/L perchloric acid did not make signif-
icant differences in DNA values (unpublished observations).
RNA extraction. -Total unfractionated RNA was extracted
from parotid glands by essentially the same procedures as de-
scribed by Chirgwin et al. (1979). The homogenizing medium
contained guanidinium thiocyanate to inhibit RNase activity.
RNA was precipitated with ethanol and acetic acid, dried, dis-
solved in sterile, diethyl pyrocarbonate-treated water, and kept
frozen at - 100TC after being divided into aliquots. Individual
aliquots of frozen RNA were thawed and used once. Only the
RNA samples that showed two sharp ribosomal RNA bands
after separation by electrophoresis on agarose gel (Maniatis et
al., 1982) were used for further studies. The ratio of A260/
A280 of the RNA samples ranged from 1.8 to 2.14, and the
DNA contamination was less than 1%.
Northern blots. -RNA samples were denatured with for-
maldehyde by being heated for 15 min at 55TC. After electro-
phoresis on 2.2 mol/L formaldehyde-1% agarose gel, the RNA
was transferred to nitrocellulose filters (Maniatis et al., 1982).
The filter was washed in 3X SSC (standard sodium citrate:
0.15 mol/L sodium chloride and 15 mmol/L sodium citrate),
air-dried, and baked for three to four h at 80TC under vacuum
for fixing of the RNA to the filter. After hybridization (de-
scribed below), autoradiographs were prepared with XO-matic
AR film (Kodak, Rochester, NY).
RNA dot blots. -RNA samples were diluted, denatured as
described above, and applied to nitrocellulose filters with a
Minifold I (Schleicher and Schuell, Keene, NH) being used as
a guide. The filters were dried and baked as described above.
After hybridization, the dots were cut out, and radioactivity
was counted in a Beckman scintillation counter (LS 9800).
Probe generation and determination of saturating concen-
tration. -Hybridization was carried out with antisense mRNA
riboprobes generated with a commercially available kit follow-
ing the manufacturer's instructions (Promega Biotech, Madi-
son, WI). For amylase riboprobe generations, the cDNA isolated
from pUC9 vector was inserted into the PstI site of pGEM-4Z
(Promega). After linearization with restriction enzyme KpnI
(BBL, Gaithersburg, MD), riboprobe transcripts were synthe-
sized with the cloned cDNA used as a template in the presence
of T7 RNA polymerase (Promega) and cytidine 5' - [a 32p]
triphosphate (Amersham Corp., Arlington Heights, IL). The
actin probe was generated similarly, except that the cDNA
template in Bluescribe vector was linearized with HindIII (Pro-
mega), and transcription was carried out in the presence of T3
RNA polymerase (Boehringer Mannheim Biochemicals, Indi-
anapolis, IN). The cDNA template was digested with DNase
I (BRL), and unincorporated label was removed with a Seph-
adex G-50 column (Nick columns, Pharmacia, Piscataway,
NJ). The specific activities of the probes were 6 and 4 x 107
cpm/pLg RNA for amylase and actin, respectively. The satu-
rating probe concentration was determined by hybridization of
nitrocellulose filters containing spots of an equal amount of
RNA to increasing concentrations of riboprobe. Hybridization
was carried out overnight at 50'C with the saturating probe
concentration and as described by Maniatis et al. (1982). After
hybridization, blots were rinsed three times (one, five, and ten
min each) with a solution containing 2x SSC and 0.1% SDS
(sodium dodecyl sulfate) at room temperature. Blots were fur-
ther washed two times in a solution of 0.1x SSC and 0.1%
SDS at 55TC for 60 and 30 min.
Statistical analysis. -The statistical significance of differ-
ences among mean values was determined by one-way analysis
of variance (ANOVA) followed by Duncan's New Multiple
Range Test.
Results.
After a single intraperitoneal injection of STZ, the rats be-
came diabetic, as evidenced by the elevated blood glucose
level (Table 1). The serum glucose level elevated to about five
times the normal level six to 12 days after the injection (Table
1). In this study, only those rats with the serum glucose level
of higher than 27.8 mmol/L (500 mg/dL) were used as diabetic
rats. The body weights of the STZ-injected rats increased only
slightly (about 4.8%) in two weeks following the injection
(Table 1), as compared with control rats, which gained about
26% during the same time period.
The insulin injection lowered the serum glucose level (Table
1), although the sugar level fluctuated much more widely in
insulin-injected rats than in normal or diabetic rats even after
seven daily injections. The body weight increased with insulin
injections. After seven days of insulin injection, the weight of
the diabetic rats increased by about 28% of the pre-injection
weight. During the three-week period of experiments, the body
weight of uninjected rats of a comparable age increased about
150 g. Despite this weight gain, the glandular contents of DNA
(per mg tissue), total protein (per pLg DNA), and amylase (per
pLg DNA) in these control rats did not change significantly
(Table 2).
Parotid contents of DNA and total protein did not change
significantly in diabetic rats or in diabetic rats treated with
TABLE 1
BODY WEIGHT AND SERUM GLUCOSE LEVEL IN CONTROL
AND DIABETIC RATS
Body Weight Serum Glucose
Treatment (g) (mmol/L)
Control 242.5 ± 2.7 (9) 6.5 ± 0.5 (9)
D6 251.3 ± 9.5 (4) 31.4* ± 1.0 (4)
D12 248.6 ± 5.5 (7) 29.4* ± 2.2 (4)
D12-I1 276.4* ± 5.7 (7) 18.9 ± 1.8 (4)
D12-17 311.9* ± 7.7 (7) 10.1 + 2.9 (10)
Values are mean ± SEM.
The numbers in parentheses denote the number of rats used for each
assay.
Control: Body weight at the time of STZ injection.
D6: Six days after streptozotocin injection.
D12: Twelve days after streptozotocin injection.
D12-I1: Twelve days after streptozotocin followed by one injection of
insulin on day 13.
D12-17: Twelve days after streptozotocin followed by seven daily in-
jections of insulin.
*Indicates the mean values that are significantly different by Duncan's
Multiple Range Test (pO0.05) from the other means in the same column.
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TABLE 2
DNA, PROTEIN, AND AMYLASE CONTENTS OF PAROTID















19.50 ± 1.76 (4)
Amylase
Units+/,g DNA
9.33 ± 1.18 (9)
8.32 ± 0.56 (4)
8.04 ± 0.41 (4)
Values are mean + SEM.
The numbers in parentheses represent numbers of rats used for each
assay.
*The three groups represent the body weight ranges at the beginning,
middle, and end of the experimental period of three weeks.
+Units represent mg of maltose released in three mn of incubation at
370C.
insulin (Table 3). However, amylase contents in parotid glands
of six- and 12-day diabetic rats were reduced to about 40% of
the control level (Table 3). Insulin increased parotid amylase
contents, which were significantly higher than in diabetic glands
and reached levels equal to about 70% of the pre-STZ level
after seven daily injections (Table 3).
Corresponding to the reduced amylase contents, the amylase
mRNA levels in parotid glands of diabetic rats were also lower
than in the control glands. The mRNA contents were reduced
to 82% and 57% of the control level in six- and 12-day diabetic
rats, respectively (Table 4). Insulin treatments of these diabetic
rats increased the amylase mRNA contents. The mRNA level
increased to about 87% of the normal level after seven days
of insulin (Table 4). However, the effect of insulin was not
immediate: The amylase mRNA content did not increase after
one injection of insulin (Table 4, Fig.).
Despite the changes in parotid levels of amylase mRNA in
diabetic rats before and after insulin treatments, the molecular
size of this mRNA did not change and was the same as that
in control glands (Fig.). Also, the level of actin mRNA was
Fig.-Northern blot of total parotid
RNA hybridized with 32P-labeled
antisense riboprobe amylase mRNA.
Parotid RNA was obtained from
control (Lane 1), six-day (lane 2),
and 12-day (lane 3) diabetic rats.
Lanes 4 and 5 contained parotid
RNA from 12-day diabetic rats in-
jected with insulin for one and seven
days, respectively. Parotid amylase
mRNA from these rats was of the
same molecular size. A comparison
of lanes 3 and 4 revealed no in-
crease in amylase mRNA in parotid
glands after an insulin injection of
diabetic rats.
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TABLE 3
DNA, PROTEIN, AND AMYLASE CONTENTS IN PAROTID
GLANDS OF CONTROL AND DIABETIC RATS
DNA
Treatment ,ug/mg Tissue
Control (17) 5.66 0.26
D6 (4) 6.12 ± 0.68
D12 (6) 6.24 ± 0.42
D12-I1 (6) 6.09 ± 0.42
D12-47 (9) 5.33 ± 0.38
















The numbers in parentheses denote the number of rats used for each
assay.
Control: Values represent means of all 17 rats listed in Table 2.
D6: Six days after streptozotocin injection.
D12: Twelve days after streptozotocin injection.
D12-I1: Twelve days after streptozotocin followed by one injection of
insulin on day 13.
D12-17: Twelve days after streptozotocin followed by seven daily in-
jections of insulin.
*The mean values are significantly different by Duncan's Multiple Range
Test (p.0.05) among the following groups: Control and D12-17 vs. D6,
D12, and D12-I1; D6 vs. D12-Il and D12-47; D12 vs. D12417.
+Units represent mg of maltose released in three min of incubation at
370C.
not affected by either STZ or insulin treatments. The level of
this non-secretory protein mRNA in parotid glands of diabetic
or insulin-injected rats was not different from that in control
rats (Table 4).
Discussion.
The elevated serum glucose level and retarded weight gains
in STZ-injected rats indicated that these rats were diabetic.
Also, the parotid acinar cells in these injected rats were filled
with lipid granules of different sizes (unpublished observa-
tions), as was described for experimentally-induced diabetic
rats (Anderson, 1983; Hand and Weiss, 1984).
The parotid content of amylase, on a per-cell (DNA) basis,
was reduced in STZ-induced diabetic rats, compared with con-
trol rats. Insulin administration reversed the effects of STZ-
induced diabetes on parotid cell contents of amylase. Thus,
the results of this study support the previous findings on the
effects of alloxan diabetes and insulin on parotid amylase con-
tents (Anderson and Johnson, 1981; Anderson, 1983).
The parotid contents of DNA and total protein did not change
in STZ-induced diabetic rats and were not different from those
of control rats, as reported previously in alloxan-induced dia-
betic rats (Anderson and Johnson, 1981). Anderson (1983) has
reported that alloxan diabetes resulted in reductions in glan-
dular contents of DNA, RNA, and protein when comparisons
were made with those values in control rats fed "a pelleted
bulk diet" to compensate for hyperphagia in the diabetic rats.
The rats in the present study were on standard pellet food, and
the DNA contents, compared based on the tissue weight, were
not significantly different among the various experimental and
control groups (Tables 2 and 3).
The STZ-induced diabetes and subsequent insulin treatment
had effects on amylase mRNA levels similar to those on am-
ylase protein levels in parotid glands. However, the changes
in amylase protein and its mRNA levels did not exactly parallel
each other during diabetogenesis or subsequent insulin treat-
ment (Tables 2 and 4). One reason for this discrepancy might
be related to fluctuations in parotid contents of amylase protein
due to variations in the secretary activity of the gland in dia-
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TABLE 4




Treatment Rats CPM/,g RNA x 10-3 CPM/pug RNA
Control 7 40.48 + 4.92 0.193 ± 0.013
D6 5 33.14+ + 6.81 0.227 + 0.033
D12 8 23.04* + 3.45 0.241 + 0.027
D12-I1 3 15.37* + 3.37 0.205 ± 0.019
D12-47 4 35.25+ + 5.60 0.197 ± 0.027
Values are mean ± SEM.
D6: Six days after streptozotocin injection.
D12: Twelve days after streptozotocin injection.
D12-I1: Twelve days after streptozotocin followed by one injection of
insulin on day 13.
D12-47: Twelve days after streptozotocin followed by seven daily in-
jections of insulin.
*Indicates the mean values that are significantly different by Duncan's
Multiple Range Test (pO0.05) from the control value.
+Indicates the mean values that are significantly different by Duncan's
Multiple Range Test (p<0.05) from the mean of D12-I1.
betic or insulin-treated diabetic rats. According to Anderson
(1983), as well as our unpublished observations, the food in-
take increases in diabetic rats. The possibility exists that the
lower level of parotid amylase was related to an elevated rate
of secretion due to increased mastication associated with hy-
perphagia in diabetic rats (Anderson, 1983). However, it is
unlikely that the level of a secretary protein amylasee) mRNA
will be reduced in glands with an increased secretary activity.
Furthermore, it has been shown previously that peroxidase lev-
els are increased and DNase is unaffected, while amylase lev-
els are reduced in parotid glands of diabetic rats (Anderson,
1983). The increase in secretary activity is likely to affect the
glandular levels of all secretary proteins equally.
The effects of diabetes and insulin on amylase protein and
its mRNA in the pancreas and parotid gland appear to be se-
lective for this secretary protein. Even among pancreatic en-
zymes of diabetic rats, only the amylase activity was markedly
decreased, while activities of trypsinogen and chymotrypsi-
nogen were increased (Ben Abdeljlil et al., 1965; Korc et al.,
1981a). Insulin appears to have an inverse effect on amylase
and chymotrypsinogen mRNA levels (Korc et al., 1981b).
Similarly, insulin seems to affect amylase selectively in rat
parotid glands as well, as mentioned above (Anderson, 1983).
As shown in this study, insulin increased amylase mRNA lev-
els in parotid glands of diabetic rats as in the pancreas. How-
ever, neither diabetes nor insulin had any effect on the level
of actin mRNA, an mRNA for a non-secretory protein in rat
parotid glands.
Thus, diabetes-induced reductions and restorations by in-
sulin of amylase protein and its mRNA in parotid glands were
quite similar to the changes that occur in the pancreas. How-
ever, the magnitude of these changes was much greater in the
pancreas than in parotid glands (Soling and Unger, 1972; Korc
et al., 1981b). In the pancreas, amylase mRNA, which is
decreased by 100-fold in rats 13 days after an injection of STZ,
increased back to normal after seven daily injections of insulin
(Korc et al., 1981b). This difference in the magnitude of
depression in amylase mRNA levels in these two digestive
glands probably reflects the relative significance of the role
that pancreatic amylase plays in converting dietary carbohy-
drates to absorbable sugars. Suppression of the production of
amylase for prevention of this conversion may constitute a
natural physiological response to elevated sugar levels in dia-
betic animals.
Although insulin increases amylase mRNA in parotid glands,
the effect of insulin on amylase mRNA synthesis did not ap-
pear to be immediate, since these mRNA levels in parotid
glands continued to show a decline even one day after insulin
treatment. On the other hand, parotid amylase levels were in-
creased a day after insulin injection of diabetic rats, suggesting
that insulin exerts its influence on amylase synthesis at the
level of translation. It has been shown previously that incu-
bation of parotid tissues with insulin stimulated the incorpo-
ration of 3H-leucine into total protein and amylase (McPherson
and Hales, 1978). Also, insulin stimulated protein synthesis in
pancreatic acinar cells in vitro (Korc et al., 1981a; Williams
and Goldfine, 1986; Okabayashi et al., 1987), as well as in
vivo (Soling and Unger, 1972). The insulin effect of increasing
protein synthesis seemed to be rapid (within one to two hours)
and occurred without changes in translatable amount of mRNA
(Okabayashi et al., 1987), leading to a suggestion that insulin
has a short-term translational and a long-term transcriptional
effect on protein synthesis.
The exact mechanism by which insulin regulates amylase
synthesis in the parotid gland or pancreas is unknown. How-
ever, a recent study of an amylase/chloramphenicol acetyl-
transferase (CAT) hybrid in transgenic mice has shown that
insulin regulates amylase synthesis at the level of transcription,
rather than by regulating the processing of mRNA or its sta-
bility (Osborn et al., 1988). It is unknown whether insulin
regulation of amylase synthesis is at the level of gene tran-
scription in parotid glands. Nevertheless, the increased level
of amylase mRNA following seven daily injections of insulin
in parotid glands of diabetic rats (Table 4) supports the sug-
gestion that insulin exerts its influence at the level of amylase
gene transcription. If, indeed, amylase gene expression is reg-
ulated by insulin, it may not be surprising that parotid (Amy-
1) and pancreatic (Amy-2) amylase genes are regulated inde-
pendently in rats, since these genes are associated with differ-
ent promoters (Hagenbuchle et al., 1981; Young et al., 1981;
Osborn et al., 1987).
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